Biblio Discovery — Demo Discovery Service

5 hasil untuk "Giulia Simoni"

Menampilkan 1–5 · 0,46 detik · RSS

  1. Artikel Jurnal Teks lengkap

    A closed-loop multi-level model of glucose homeostasis

    Cansu Uluseker; Giulia Simoni; Luca Marchetti dkk.

    PLOS ONE, Vol. 13 No. 2 · 2018 · Inggris · PLOS Scopus

    Background: The pathophysiologic processes underlying the regulation of glucose homeostasis are considerably complex at both cellular and systemic level. A comprehensive and structured specification for the several layers of abstraction of glucose metabolism is often elusive, an issue currently…

    Juga tersedia di: DOAJ

  2. Artikel Jurnal Teks lengkap

    A Retrospective Analysis of the COVID-19 Pandemic Evolution in Italy

    Anna Fochesato; Giulia Simoni; Federico Reali dkk.

    Biology, Vol. 10 No. 4 · 2021 · Inggris · DOAJ Scopus

    Late 2019 saw the outbreak of COVID-19, a respiratory disease caused by the new coronavirus SARS-CoV-2, which rapidly turned into a pandemic, killing more than 2.77 million people and infecting more than 126 million as of late March 2021. Daily collected data on infection cases and hospitalizations…

  3. Artikel Jurnal

    QSPcc reduces bottlenecks in computational model simulations

    Danilo Tomasoni; Alessio Paris; Stefano Giampiccolo dkk.

    Communications Biology, Vol. 4 No. 1 · 2021 · Inggris · DOAJ Scopus

    Lombardo and colleagues present QSPcc, a computational code compiler designed to convert code from popular scientific programming languages, such as MATLAB or R, into fast-running C code. This reduces the computational load required for complex modelling approaches and reduces user investment…

  4. Artikel Jurnal

    A Quantitative Systems Pharmacology Model of Gaucher Disease Type 1 Provides Mechanistic Insight Into the Response to Substrate Reduction Therapy With Eliglustat

    Ruth Abrams; Chanchala D. Kaddi; Mengdi Tao dkk.

    CPT: Pharmacometrics & Systems Pharmacology, Vol. 9 No. 7 · 2020 · Inggris · DOAJ Scopus

    Gaucher’s disease type 1 (GD1) leads to significant morbidity and mortality through clinical manifestations, such as splenomegaly, hematological complications, and bone disease. Two types of therapies are currently approved for GD1: enzyme replacement therapy (ERT), and substrate reduction therapy…